Mirum Pharmaceuticals, Inc.

MIRM

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001759425

SEC filings (opens in a new tab)

In the last 90 days, Mirum Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 9 sales; 326 institutions reported holding it in 13F filings for Q2 2026, worth $8.36B in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Mirum Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of MIRM: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Of which not filed for Q2 2022	Q2 2022	Change
Holders	99	2	110	+13
Shares	26.8M	19.2K	29.3M	+2.53M (+9.5%)
Value	$590.4M	$423.0K	$569.4M	−$20.6M (−3.5%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to MIRM in Q2 2022
Institution	Shares	Value	% of portfolio
Tang Capital Management LLC	100,000	$1.95M	0.30%
Jackson Creek Investment Advisors LLC	37,356	$938.0K	0.38%
Calamos Advisors LLC	42,521	$828.0K	0.00%
Swiss National Bank	37,400	$728.0K	0.00%
Principal Financial Group Inc	34,971	$681.0K	0.00%
Los Angeles Capital Management LLC	29,620	$576.0K	0.00%
Algert Global LLC	26,170	$509.0K	0.04%
D. E. Shaw & Co., Inc.	24,836	$483.0K	0.00%
SEI Investments Co	22,337	$435.0K	0.00%
Rhumbline Advisers	18,344	$357.0K	0.00%
State of Wisconsin Investment Board	16,926	$329.0K	0.00%
New York Life Investments Alternatives	12,022	$234.0K	0.21%
Marshall Wace, LLP	10,960	$214.0K	0.00%
Credit Suisse AG	10,483	$204.0K	0.00%
MetLife Investment Management	8,428	$164.0K	0.00%
Lazard Asset Management LLC	2,442	$47.0K	0.00%
Metropolitan Life Insurance Co	978	$19.0K	0.00%
Wells Fargo & Company	453	$9.00K	0.00%
HighMark Wealth Management LLC	465	$9.00K	0.01%
Ellevest, Inc.	82	$2.00K	0.00%
Aquatic Capital Management LLC	100	$2.00K	0.00%
Raffa Wealth Management, LLC	32	$623	0.00%
The PNC Financial Services Group, Inc.	18	$0	0.00%
Glassman Wealth Services	8	$0	0.00%

Sold out (11)

Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of MIRM in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Sio Capital Management, LLC	161,285	$3.55M
Point72 Asset Management, L.P.	153,389	$3.38M
Laurion Capital Management LP	43,908	$967.0K
Millennium Management LLC	23,115	$509.0K
Graham Capital Management, L.P.	21,691	$477.0K
Corton Capital Inc.	15,848	$349.0K
Gsa Capital Partners LLP	14,869	$327.0K
AdvisorShares Investments LLC	13,100	$288.0K
Delphia (USA) Inc.	10,958	$241.0K
HRT Financial LP	10,774	$237.0K
Point72 Hong Kong Ltd	364	$8.00K

Not filed for Q2 2022 yet (2)

Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding MIRM in Q1 2022 that haven't filed for Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Golden State Equity Partners	18,730	$412.0K
Amalgamated Financial Corp.	516	$11.0K